drugset / Trial / NCT00212186
Selenium Supplementation of Patients With Cirrhosis
Completed
48 enrolled
Vanderbilt University
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · collab
RandomizedParallel-groupDouble-blind
Summary
The purpose of this study is to determine whether patients with liver disease can improve their nutritional selenium status by taking supplemental selenium.
Timeline
- Start
- 1998-10
- Primary completion
- 2003-11
- Completion
- 2003-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Selenomethionine | Other / unclassified | 200 ug | — |
| Subject | selenate | Unknown | 200 ug | — |